Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jennie Chan is active.

Publication


Featured researches published by Jennie Chan.


Nature Medicine | 2014

Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection.

Peter Liehl; Vanessa Zuzarte-Luis; Jennie Chan; Thomas Zillinger; Fernanda G. Baptista; Daniel Carapau; Madlen Konert; Kirsten K. Hanson; Celine Carret; Caroline Lassnig; Mathias Müller; Ulrich Kalinke; Mohsan Saeed; Angelo Ferreira Chora; Douglas T. Golenbock; Birgit Strobl; Miguel Prudêncio; Luis Pedro Coelho; Stefan H. I. Kappe; Giulio Superti-Furga; Andreas Pichlmair; Ana M. Vigário; Charles M. Rice; Katherine A. Fitzgerald; Winfried Barchet; Maria M. Mota

Before they infect red blood cells and cause malaria, Plasmodium parasites undergo an obligate and clinically silent expansion phase in the liver that is supposedly undetected by the host. Here, we demonstrate the engagement of a type I interferon (IFN) response during Plasmodium replication in the liver. We identified Plasmodium RNA as a previously unrecognized pathogen-associated molecular pattern (PAMP) capable of activating a type I IFN response via the cytosolic pattern recognition receptor Mda5. This response, initiated by liver-resident cells through the adaptor molecule for cytosolic RNA sensors, Mavs, and the transcription factors Irf3 and Irf7, is propagated by hepatocytes in an interferon-α/β receptor–dependent manner. This signaling pathway is critical for immune cell–mediated host resistance to liver-stage Plasmodium infection, which we find can be primed with other PAMPs, including hepatitis C virus RNA. Together, our results show that the liver has sensor mechanisms for Plasmodium that mediate a functional antiparasite response driven by type I IFN.


Proceedings of the National Academy of Sciences of the United States of America | 2015

Suppression of systemic autoimmunity by the innate immune adaptor STING

Shrutie Sharma; Allison M. Campbell; Jennie Chan; Stefan A. Schattgen; Gregory M. Orlowski; Ribhu Nayar; Annie Huyler; Kerstin Nundel; Chandra Mohan; Leslie J. Berg; Mark J. Shlomchik; Ann Marshak-Rothstein; Katherine A. Fitzgerald

Significance Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease that presents with a diverse array of clinical symptoms and afflicts over 1.5 million Americans. Current treatments involve immunosuppressive regimens associated with debilitating and adverse effects. With the description of a role for innate signaling in SLE, safe and efficient therapies that block Toll-like receptors also have been stymied by the relative short in vivo half lives of known inhibitors and the dangerous outcome of complete MyD88 blockade. Key natural regulators of the disease process are not well described but are more likely to provide disease-specific therapeutics with fewer adverse effects. In this study, we have identified a novel function for Stimulator of interferon genes as a suppressor of disease and a target for future SLE therapeutics. Cytosolic DNA-sensing pathways that signal via Stimulator of interferon genes (STING) mediate immunity to pathogens and also promote autoimmune pathology in DNaseII- and DNaseIII-deficient mice. In contrast, we report here that STING potently suppresses inflammation in a model of systemic lupus erythematosus (SLE). Lymphoid hypertrophy, autoantibody production, serum cytokine levels, and other indicators of immune activation were markedly increased in STING-deficient autoimmune-prone mice compared with STING-sufficient littermates. As a result, STING-deficient autoimmune-prone mice had significantly shorter lifespans than controls. Importantly, Toll-like receptor (TLR)-dependent systemic inflammation during 2,6,10,14-tetramethylpentadecane (TMPD)-mediated peritonitis was similarly aggravated in STING-deficient mice. Mechanistically, STING-deficient macrophages failed to express negative regulators of immune activation and thus were hyperresponsive to TLR ligands, producing abnormally high levels of proinflammatory cytokines. This hyperreactivity corresponds to dramatically elevated numbers of inflammatory macrophages and granulocytes in vivo. Collectively these findings reveal an unexpected negative regulatory role for STING, having important implications for STING-directed therapies.


Journal of Immunology | 2015

Cutting Edge: A Natural Antisense Transcript, AS-IL1alpha, Controls Inducible Transcription of the Proinflammatory Cytokine IL-1alpha

Jennie Chan; Maninjay K. Atianand; Zhaozhao Jiang; Susan Carpenter; Daniel Aiello; Roland Elling; Katherine A. Fitzgerald; Daniel R. Caffrey

Natural antisense transcripts (NATs) are a class of long noncoding RNAs (lncRNAs) that are complementary to other protein-coding genes. Although thousands of NATs are encoded by mammalian genomes, their functions in innate immunity are unknown. In this study, we identified and characterized a novel NAT, AS-IL1α, which is partially complementary to IL-1α. Similar to IL-1α, AS-IL1α is expressed at low levels in resting macrophages and is induced following infection with Listeria monocytogenes or stimulation with TLR ligands (Pam3CSK4, LPS, polyinosinic-polycytidylic acid). Inducible expression of IL-1α mRNA and protein were significantly reduced in macrophages expressing shRNA that target AS-IL1α. AS-IL1α is located in the nucleus and did not alter the stability of IL-1α mRNA. Instead, AS-IL1α was required for the recruitment of RNA polymerase II to the IL-1α promoter. In summary, our studies identify AS-IL1α as an important regulator of IL-1α transcription during the innate immune response.


Journal of Immunology | 2015

Cutting Edge: A Natural Antisense Transcript, AS-IL1α, Controls Inducible Transcription of the Proinflammatory Cytokine IL-1α

Jennie Chan; Maninjay K. Atianand; Zhaozhao Jiang; Susan Carpenter; Daniel Aiello; Roland Elling; Katherine A. Fitzgerald; Daniel R. Caffrey

Natural antisense transcripts (NATs) are a class of long noncoding RNAs (lncRNAs) that are complementary to other protein-coding genes. Although thousands of NATs are encoded by mammalian genomes, their functions in innate immunity are unknown. In this study, we identified and characterized a novel NAT, AS-IL1α, which is partially complementary to IL-1α. Similar to IL-1α, AS-IL1α is expressed at low levels in resting macrophages and is induced following infection with Listeria monocytogenes or stimulation with TLR ligands (Pam3CSK4, LPS, polyinosinic-polycytidylic acid). Inducible expression of IL-1α mRNA and protein were significantly reduced in macrophages expressing shRNA that target AS-IL1α. AS-IL1α is located in the nucleus and did not alter the stability of IL-1α mRNA. Instead, AS-IL1α was required for the recruitment of RNA polymerase II to the IL-1α promoter. In summary, our studies identify AS-IL1α as an important regulator of IL-1α transcription during the innate immune response.


Journal of Biological Chemistry | 2014

RNA and β-Hemolysin of Group B Streptococcus Induce Interleukin-1β (IL-1β) by Activating NLRP3 Inflammasomes in Mouse Macrophages

Rahul Gupta; Shubhendu Ghosh; Brian G. Monks; Rosane B. DeOliveira; Te-Chen Tzeng; Parisa Kalantari; Anubhab Nandy; Bornali Bhattacharjee; Jennie Chan; Fabianno Ferreira; Vijay A. K. Rathinam; Shrutie Sharma; Egil Lien; Neal S. Silverman; Katherine A. Fitzgerald; Arnaud Firon; Patrick Trieu-Cuot; Philipp Henneke; Douglas T. Golenbock

Background: Group B Streptococcus (GBS) activates the NLRP3 inflammasome. Results: GBS RNA escapes the phagolysosome and activates the NLRP3 inflammasome in a β-hemolysin-dependent fashion. RNA-NLRP3 interaction and activation are enhanced by lysosomal leakage. Conclusion: RNA activates the NLRP3 inflammasome in synergy with phagolysosomal proteins. Significance: The NLRP3 inflammasome responds to bacterial invasion via RNA recognition subsequent to phagolysosomal degradation. The inflammatory cytokine IL-1β is critical for host responses against many human pathogens. Here, we define Group B Streptococcus (GBS)-mediated activation of the Nod-like receptor-P3 (NLRP3) inflammasome in macrophages. NLRP3 activation requires GBS expression of the cytolytic toxin, β-hemolysin, lysosomal acidification, and leakage. These processes allow the interaction of GBS RNA with cytosolic NLRP3. The present study supports a model in which GBS RNA, along with lysosomal components including cathepsins, leaks out of lysosomes and interacts with NLRP3 to induce IL-1β production.


European Journal of Immunology | 2016

Emerging role of long noncoding RNAs as regulators of innate immune cell development and inflammatory gene expression

Roland Elling; Jennie Chan; Katherine A. Fitzgerald

The innate immune system represents the first line of defense during infection and is initiated by the detection of conserved microbial products by germline‐encoded pattern recognition receptors (PRRs). Sensing through PRRs induces broad transcriptional changes that elicit powerful inflammatory responses. Tight regulation of these processes depends on multiple regulatory checkpoints, including noncoding RNA species such as microRNAs. In addition, long noncoding RNAs (lncRNAs) have recently gained attention as important regulators of gene expression acting through versatile interactions with DNA, RNA, or proteins. As such, these RNAs have a multitude of mechanisms to modulate gene expression. Here, we summarize recent advances in this rapidly moving and evolving field. We highlight the contribution of lncRNAs to both the development and activation of innate immune cells, whether it is in the nucleus, where lncRNAs alter the transcription of target genes through interaction with transcription factors, chromatin‐modifying complexes or heterogenous ribonucleoprotein complexes, or in the cytosol where they can control the stability of target mRNAs. In addition, we discuss experimental approaches required to comprehensively investigate the function of a candidate noncoding RNA locus, including loss‐of‐function approaches encompassing genomic deletions, RNA interference, locked nucleic acids, and various adaptions of the CRISPR/Cas9 technology.


Journal of Immunology | 2016

Cutting Edge: Novel Tmem173 Allele Reveals Importance of STING N Terminus in Trafficking and Type I IFN Production.

Guy Surpris; Jennie Chan; Mikayla R. Thompson; Vladimir Ilyukha; Beiyun C. Liu; Maninjay K. Atianand; Shrutie Sharma; Tatyana O. Volkova; Irina Smirnova; Katherine A. Fitzgerald; Alexander Poltorak

With the stimulator of IFN genes (STING) C terminus being extensively studied, the role of the N-terminal domain (NTD) of STING remains an important subject of investigation. In this article, we identify novel mutations in NTD of Sting of the MOLF strain in response to HSV and Listeria monocytogenes both in vitro and in vivo. These mutations are responsible for low levels of IFN-β caused by failure of MOLF STING to translocate from the endoplasmic reticulum. These data provide evidence that the NTD of STING affects DNA responses via control of trafficking. They also show that the genetic diversity of wild-derived mice resembles the diversity observed in humans. Several human alleles of STING confer attenuated IFN-I production similar to what we observe with the MOLF Sting allele, a crucial functional difference not apparent in classical inbred mice. Thus, understanding the functional significance of polymorphisms in MOLF STING can provide basic mechanistic insights relevant to humans.


Immunity | 2011

Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome.

Shrutie Sharma; Rosane B. DeOliveira; Parisa Kalantari; Peggy Parroche; Nadege Goutagny; Zhaozhao Jiang; Jennie Chan; Daniella Castanheira Bartholomeu; Fanny N. Lauw; J. Perry Hall; Glen N. Barber; Ricardo T. Gazzinelli; Katherine A. Fitzgerald; Douglas T. Golenbock


Cell Reports | 2014

Dual engagement of the NLRP3 and AIM2 inflammasomes by plasmodium-derived hemozoin and DNA during malaria.

Parisa Kalantari; Rosane B. DeOliveira; Jennie Chan; Yolanda Corbett; Vijay A. K. Rathinam; Andrea Stutz; Eicke Latz; Ricardo T. Gazzinelli; Douglas T. Golenbock; Katherine A. Fitzgerald


Lupus science & medicine | 2016

II-13 Suppression of systemic autoimmunity by the innate immune adaptor sting

Shruti Sharma; Allison M. Campbell; Jennie Chan; Stefan A. Schattgen; Gregory M. Orlowski; Ribhu Nayar; Annie Huyler; Kerstin Nundel; Chandra Mohan; Leslie J. Berg; Mark J. Shlomchik; Ann Marshak-Rothstein; Katherine A. Fitzgerald

Collaboration


Dive into the Jennie Chan's collaboration.

Top Co-Authors

Avatar

Katherine A. Fitzgerald

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Douglas T. Golenbock

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Rosane B. DeOliveira

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Shrutie Sharma

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Annie Huyler

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Maninjay K. Atianand

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Parisa Kalantari

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Roland Elling

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Shruti Sharma

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Stefan A. Schattgen

University of Massachusetts Medical School

View shared research outputs
Researchain Logo
Decentralizing Knowledge